GlassScriptFineline II Sterox
Payments companies reported to CMS as associated with Fineline II Sterox. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Fineline II Sterox, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Fineline II Sterox
These are the largest totals companies reported as associated with Fineline II Sterox. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Adam Lottick | Trumbull, CT | Clinical Cardiac Electrophysiology | $14,505.19 |
| Apoor Patel | Sugar Land, TX | Clinical Cardiac Electrophysiology | $9,222.60 |
| Christopher Latanich | Duluth, MN | Cardiovascular Disease | $4,192.57 |
| Keith Kyker | Powell, TN | Clinical Cardiac Electrophysiology | $170.08 |
| Jose Cuellar Silva | Webster, TX | Clinical Cardiac Electrophysiology | $140.07 |
| Zoya Shir | Hackensack, NJ | Nurse Practitioner | $131.37 |
| Francesco Santoni-Rugiu | New York, NY | Clinical Cardiac Electrophysiology | $131.36 |
| Taya Glotzer | Hackensack, NJ | Clinical Cardiac Electrophysiology | $131.36 |
| Glauco Radoslovich | Hackensack, NJ | Clinical Cardiac Electrophysiology | $131.36 |
| Vandana Rathod | Hackensack, NJ | Family | $131.36 |
Prescribed Fineline II Sterox?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.